Genomic Profiling of Hereditary Breast Cancer
Author: Lars van Brakel Andersen
Publisher:
Published: 2019
Total Pages: 188
ISBN-13:
DOWNLOAD EBOOKRead and Download eBook Full
Author: Lars van Brakel Andersen
Publisher:
Published: 2019
Total Pages: 188
ISBN-13:
DOWNLOAD EBOOKAuthor: Bernardo L. Rapoport
Publisher: Karger Medical and Scientific Publishers
Published: 2020-10-20
Total Pages: 109
ISBN-13: 3318068187
DOWNLOAD EBOOKCancer is a multifaceted disease in which genetic changes induce uncontrolled tumor growth. Genomic characterization of cancer is now leading to better diagnostic, prognostic and predictive biomarkers, and effective individualized management. 'Fast Facts: Comprehensive Genomic Profiling' provides a crash course in the science, methods and application of genomic profiling. Assuming only the most basic knowledge – or memory – of cell biology, the authors provide an overview of DNA and RNA biology and next-generation sequencing. This sets in context the descriptions of prognostic and predictive biomarkers for different cancer types and genomic-based treatments. Finally, but importantly, some of the practicalities of gaining and interpreting genomic information are described. Whether you need a primer or a refresher, this short colorful book demystifies this complex subject. Contents: • Genetic mutations and biomarkers • Understanding next-generation sequencing • Elements of comprehensive genomic profiles • Role in precision oncology • Predictive and prognostic biomarkers • Overcoming barriers to genotype-directed therapy
Author: Monica Castiglione
Publisher: Springer Science & Business Media
Published: 2009-07-11
Total Pages: 483
ISBN-13: 0387751157
DOWNLOAD EBOOKAdjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.
Author: Luigi Marchionni
Publisher: DIANE Publishing
Published: 2009-05
Total Pages: 230
ISBN-13: 1437911048
DOWNLOAD EBOOKAssesses the evidence that three marketed gene expression-based assays improve prognostic accuracy, treatment choice, and health outcomes in women diagnosed with early stage breast cancer. Three gene expression assays were evaluated; Oncotype DX¿, MammaPrint® and the Breast Cancer Profiling (BCP or H/I ratio) test, and for gene expression signatures underlying the assays. They sought evidence on: analytic performance of tests; clinical validity; clinical utility; harms; and impact on clinical decision making and health care costs. Conclusions: Oncotype DX is furthest along the validation pathway, with retrospective evidence that it predicts distant spread and chemotherapy benefit to a clinically relevant extent over standard predictors. Illus.
Author: Andrew Seto
Publisher:
Published: 2015
Total Pages:
ISBN-13:
DOWNLOAD EBOOKAuthor: Jeffrey E. Green
Publisher: IOS Press
Published: 2004
Total Pages: 104
ISBN-13: 9781586034603
DOWNLOAD EBOOKBased on cutting-edge research with more than 1,000 married couples, "Love Me Slender" shows you how to bolster your resolve by strengthening your relationship, offering a fresh approach to weight loss that will turn your spouse from diet saboteur into your most loyal health ally. Eat right. Stay active. Good health follows from a few simple habits, yet millions of us struggle every day to put these habits into practice. "Love Me Slender" offers new solutions based on a remarkable insight: The powerful connection we share with our mate can influence what we eat, how much we exercise, how well we age, and ultimately how long we live. Strengthening this connection, and using it to influence our daily habits, holds the key to better health. Over the course of their twenty-year collaboration, Drs. Thomas Bradbury and Benjamin Karney have witnessed how difficult it is for partners to give each other the support they both really need--especially around emotionally loaded topics like unhealthy eating habits and weight loss. As codirectors of the Relationship Institute at UCLA, they have analyzed hundreds of conversations between partners seeking to change their eating and exercise habits, and they have identified the specific principles that determine whether couples struggle--or succeed--in their quest to improve their health. Featuring case studies, self-assessments, and sound practical advice, "Love Me Slender" is an eye-opening, uplifting guide that shows relationship partners how to discover the right ways--and avoid the pitfalls--of supporting one another in their lifelong pursuit of better health.
Author: Barbara T. Zimmerman
Publisher: Univ. Press of Mississippi
Published: 2009-09-18
Total Pages: 128
ISBN-13: 1604730447
DOWNLOAD EBOOKThis book by a scientist whose background is in cellular and molecular biology examines the fearsome disease that strikes one in eight women in the United States. Although women are more likely to die of heart disease or of lung cancer, a diagnosis of breast cancer is the medical pronouncement that a woman is most likely to fear. It kills more than 40,000 Americans annually. Why are some women more vulnerable than others? The interplay between genetics and environment is suspected. Thus this book for general readers will help them understand the genetic basis of both sporadic and inherited breast cancers. Although only five to ten percent of breast cancer patients have inherited mutations in these genes, all women need to understand the genetic implications of the disease. In clear, concise language Barbara T. Zimmerman guides the reader through the complexities, discussing in detail the genes that are known to increase susceptibility and the ways they are passed on. Examining the general biology of breast cancer, Zimmerman describes how sporadic and inherited forms of the disease arise and how the location of the tumors can affect the body. She discusses genetic mutations and their roles in the development of tumors and tells how these potentially cancer-inducing genes were discovered. Covered too are the issues of risk, prevention, screening, diagnosis, therapy, and genetic testing and counseling. Zimmerman concludes with a comprehensive analysis of current research and with an emphasis on how a woman's understanding of inherited breast cancer can help doctors seeking to design better methods for prevention and therapy. A useful list of resources for further information about the genetic causes of breast cancer is included.
Author: Ravi Salgia
Publisher: Springer
Published: 2019-06-26
Total Pages: 238
ISBN-13: 3030178323
DOWNLOAD EBOOKThis book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient’s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.
Author: National Research Council
Publisher: National Academies Press
Published: 2001-06-04
Total Pages: 34
ISBN-13: 0309075505
DOWNLOAD EBOOKX-ray mammography screening is the current mainstay for early breast cancer detection. It has been proven to detect breast cancer at an earlier stage and to reduce the number of women dying from the disease. However, it has a number of limitations. These current limitations in early breast cancer detection technology are driving a surge of new technological developments, from modifications of x-ray mammography such as computer programs that can indicate suspicious areas, to newer methods of detection such as magnetic resonance imaging (MRI) or biochemical tests on breast fluids. To explore the merits and drawbacks of these new breast cancer detection techniques, the Institute of Medicine of the National Academy of Sciences convened a committee of experts. During its year of operation, the committee examined the peer-reviewed literature, consulted with other experts in the field, and held two public workshops. In addition to identifying promising new technologies for early detection, the committee explored potential barriers that might prevent the development of new detection methods and their common usage. Such barriers could include lack of funding from agencies that support research and lack of investment in the commercial sector; complicated, inconsistent, or unpredictable federal regulations; inadequate insurance reimbursement; and limited access to or unacceptability of breast cancer detection technology for women and their doctors. Based on the findings of their study, the committee prepared a report entitled Mammography and Beyond: Developing Technology for Early Detection of Breast Cancer, which was published in the spring of 2001. This is a non-technical summary of that report.
Author:
Publisher:
Published: 2006
Total Pages: 70
ISBN-13:
DOWNLOAD EBOOKTo be able to apply the newest genetic analysis technologies in breast cancer research, enough DNA material must be available to perform this analysis. Often this is impossible with the minute amounts of tissue obtained via fine needle aspiration or laser capture microdissection currently the best methods available for removal of small amounts of tissue. Therefore whole genome-based DNA amplification techniques (e.g. PCR) are essential. The aim of this proposal was to evaluate a newly developed method, balanced PCR, which overcomes the difficulty of non-linear PCR-amplification of complex genomes and faithfully retains the difference among corresponding genes or gene fragments. In the three years of work we demonstrated the application of balanced PCR in performing genomic profiling of breast CA cell lines and samples (part of Tasks 2 and 3). In the second year we demonstrated the application of the method for gene expression profiling of breast CA cell lines (Task 1). This report describes the work conducted over the three years.